ATTACC CAP retweetledi
Winnipeg-based research project testing out pneumonia treatment winnipeg.ctvnews.ca/winnipeg-based…
English
ATTACC CAP
77 posts
ATTACC CAP
@ATTACC_CAP
Antithrombotic Therapy to Ameliorate Clinical Complications of Community Acquired Pneumonia
Winnipeg, Manitoba Katılım Ekim 2020
53 Takip Edilen350 Takipçiler
ATTACC CAP retweetledi
Congrats to the UM team awarded $6.9 million by the @CIHR_IRSC to lead an international trial of a steroid drug for pneumonia. The grant will enable expansion of a network of hospital-ward research sites, helping Canada prepare for future pandemics. news.umanitoba.ca/um-team-receiv…
English
ATTACC CAP retweetledi
Today, Minister of Health Mark Holland announced a $43M investment in 14 new Canadian-led #ClinicalTrials to assess treatments and tools with the potential to save lives.
canada.ca/en/institutes-…
English
We are so excited to expand ATTACC-CAP to include corticosteroids with the introduction of the newly funded DEFEND-CAP domain!
University of Manitoba@umanitoba
Exciting news! UM team receives $6.9 million to test pneumonia treatment and expand the network of research sites. Find out more at news.umanitoba.ca/um-team-receiv… #UManitoba #UMResearch
English
ATTACC CAP retweetledi
200 patients enrolled in ATTACC-CAP!!
💯 💯
Thanks to all our patient participants, their families, our sites, investigators, coordinators, and large number of partners!
@ATTACC_CAP
English
ATTACC CAP retweetledi
We are pleased to announce an investment
of $500K allocated over 5 years designated to support the ATTACC-CAP trail led by @umanitoba researcher @RZarychanski, this will be the second-largest clinical trial led out of Manitoba.
Read full news release: bit.ly/44gf40Q
English
ATTACC CAP retweetledi
Thanks to @N2Canada for creating this infographic all about #InternationalClinicalTrialsDay!
English
ATTACC CAP retweetledi
Honored to be recognized as @DoctorsManitoba top 40 under 40! This represents the efforts of a large research team - through COVID and now beyond…. It’s thanks to a productive and enabling team and mentors that we can innovate in medicine, for the benefits of our patients.
Doctors Manitoba@DoctorsManitoba
English
Our next phase of ATTACC, ATTACC-CAP, has been generously funded by @Research_MB! Congratulations to our Manitoba PIs @RZarychanski and @sylvainlother
Research Manitoba@Research_MB
We are pleased to announce an investment of $500K allocated over 5 years designated to support the ATTACC-CAP trail led by @umanitoba researcher @RZarychanski, this will be the second-largest clinical trial led out of Manitoba. Read full news release: bit.ly/44gf40Q
English
ATTACC PI Dr. Ryan Zarychanski is being recognized as Doctors Manitoba Physician of the Year. Congratulations @RZarychanski! We look forward to your leadership in the next chapter of the ATTACC trial.
Doctors Manitoba@DoctorsManitoba
Physician of the Year, Dr. Ryan Zarychanski is being recognized for his truly groundbreaking work leading world-wide efforts to rapidly identify effective COVID-19 treatments. @RZarychanski
English
ATTACC CAP retweetledi
Thanks to the authors of these 6 high quality RCTs we were able to document that full anticoagulation is improving survival in non-critically-ill #covid19
Swiss COVID-HEP
#PROTHROMCOVID
@ATTACC_COVID
@ACTIV4a
@remap_cap
#RAPIDtrial
@CovidHep
BEMICOP
🔗 link.springer.com/article/10.100…
English
ATTACC CAP retweetledi
🔥 This week we'll be discussing the hot topic of VTE Prophylaxis in COVID-19
‼️ Our latest protocol is published on Ask Mayo Expert (AME): mayocl.in/35QZcJu
Go to Inpatient management (adult) ➡️ Inpatient care ➡️ COVID-19 VTE Prophylaxis in Hospitalized Patients
English
ATTACC CAP retweetledi
Practice changing work from the #mpRCT and efforts of @ACTIV4a @ATTACC_COVID @remap_cap. @nih_nhlbi @NIH guidelines recommending therapeutic heparin for moderately ill hospitalized patients with #Covid_19 based on our @NEJM papers @NIHCOVIDTxGuide @UPMC @PittTweet
Mary Cushman 🫀🧠🩸@MaryCushmanMD
Breaking news on #Covid_19 treatment from @nih_nhlbi! A recommendation for full anticoagulation with low molecular weight heparin for hospitalized patients. Please spread the word! bit.ly/3n1sZF8
English
ATTACC CAP retweetledi
A step forward - therapeutic LWMH recommended for hospitalized non-critically I’ll patients with COVID19 @PatrickLawlerMD @ecgoligher @ATTACC_COVID @remap_cap @ACTIV4a @CritCareReviews @accpchest @WHO
Saskia Middeldorp@MiddeldorpS
1/2 Breaking from #ASH21 VTE guidelines session: Dr Sanfillipo presents the preliminary recommendation in acutely ill (not critically ill) patients with #COVID19: suggest to use therapeutic LMWH over prophylactic dose LMWH
English
ATTACC CAP retweetledi
@ecgoligher @PatrickLawlerMD and @RZarychanski present the results of the ATTACC trial, platform trials and the global collaboration involved @CCCForum #CCCF2021 with @JohnGranton1 and @charlot_summers
English
ATTACC CAP retweetledi
#CCCF2021
Keynote address
Monday December 6, 4:45pm
Anticoagulation in COVID-19
by @RZarychanski @ecgoligher @PatrickLawlerMD
criticalcarecanada.com
English
ATTACC CAP retweetledi
Superb @UofT_DoM Grand Rounds by @ecgoligher & @PatrickLawlerMD on the background, statistical approach & interpretation of the adaptive Bayesian design multiplatform @ATTACC_COVID / @ACTIV4a / @remap_cap anticoag in COVID trial.
nejm.org/doi/full/10.10…
nejm.org/doi/full/10.10…
English